Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of locally advanced non‐small cell lung cancer: State of the art and future directions
Da Miao, Jing Zhao, Ying Han, et al.
Cancer Communications (2023) Vol. 44, Iss. 1, pp. 23-46
Open Access | Times Cited: 35

Showing 26-50 of 35 citing articles:

Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
Shanshan Nie, Shan Zhang, Ruipeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial–mesenchymal transition in lung adenocarcinoma
Yanxin Dong, Jiale Zhang, Shun Xie, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 2
Closed Access | Times Cited: 1
Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment
Tsung‐Ming Yang, Yu‐Hung Fang, Chieh-Mo Lin, et al.
Diagnostics (2024) Vol. 14, Iss. 10, pp. 998-998
Open Access | Times Cited: 1
Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy
Lin Chen, Wen-Da Chen, Yuxin Xu, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176871-176871
Closed Access | Times Cited: 1
CAF-derived exosome-miR-3124-5p promotes malignant biological processes in NSCLC via the TOLLIP/TLR4-MyD88-NF-κB pathway
Tao Sun, Qinghua Song, Hua Liu
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 1, pp. 133-148
Closed Access | Times Cited: 1
Cd8+T Cells Infiltrating into Tumors Were Controlled by Immune Status of Draining Lymph Nodes and Correlated with Non-Small Cell Lung Cancer (Nsclc) Patients’ Prognosis Treated with Chemoimmunotherapy
Zhexin Bai, Xu Cheng, Tianyu Ma, et al.
(2024)
Closed Access
Construction of the core symptom cluster management program for patients with lung cancer undergoing chemotherapy: a Delphi study
Le Zhang, Yuanyuan Luo, Dongmei Mao, et al.
Research Square (Research Square) (2024)
Open Access
NEOADJUVANT CHEMORADIOTHERAPY IN THE MULTIMODALITY TREATMENT OF STAGE IIIA(N2) NON-SMALL CELL LUNG CANCER (NSCLC)
V D Zakharychev, Prokip Gordiichuk
Oncology (2024) Vol. 25, Iss. 1, pp. 49-53
Closed Access
Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling
Victoria Ferrari, Baharia Mograbi, Jocelyn Gal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9991-9991
Open Access
Pneumocystis pneumonia in stage IIIA lung adenocarcinoma with immune-related acute kidney injury and thoracic radiotherapy: A case report
Yawen Zheng, Jia-Chao Pan, Jinfeng Wang, et al.
World Journal of Radiology (2024) Vol. 16, Iss. 9, pp. 482-488
Open Access
A retrospective comparison of induction chemoimmunotherapy versus chemotherapy followed by concurrent chemoradiotherapy and consolidation immunotherapy in stage III non-small cell lung cancer
Jing Zhao, Da Miao, Jiaqi Zhou, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
CD8+ T cells infiltrating into tumors were controlled by immune status of pulmonary lymph nodes and correlated with non-small cell lung cancer (NSCLC) patients’ prognosis treated with chemoimmunotherapy
Zhexin Bai, Xu Cheng, Tianyu Ma, et al.
Lung Cancer (2024) Vol. 197, pp. 107991-107991
Closed Access
Network meta-analysis on the efficacy and safety of management for resectable stage IIIA-N2 non-small cell lung cancer
Qiduo Yu, Haoshuai Yang, Fei Xiao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Evaluation of the efficacy of PD‑1/PD‑L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene‑negative advanced‑stage lung adenocarcinoma: A retrospective cohort study
Xiaozun Yang, Xin Li, Ke Huang, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access
Exosome-Derived miRNAs in Liquid Biopsy for Lung Cancer
Israel Martínez-Espinosa, José A. Serrato, Carlos Cabello-Gutiérrez, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1608-1608
Open Access
[TIM3+CD8+ T Cell Expression and Clinical Significance in the Central and Non-central Tumor Microenvironment of Non-small Cell Lung Cancer].
Jia-juan Wu, Shiying Guo, Lei-lei Lv, et al.
PubMed (2024) Vol. 27, Iss. 12, pp. 903-910
Closed Access
Previous Page - Page 2

Scroll to top